BlackRock Science and Technology Trust of Beneficial Interest
| NYSE: BST | Financial Services / Asset Management / USA |
| 31.35 | -0.4500 | -1.42% | Vol 72.94K | 1Y Perf -28.05% |
| Mar 24th, 2023 16:00 DELAYED |
| BID | 31.20 | ASK | 31.90 | ||
| Open | 31.70 | Previous Close | 31.80 | ||
| Pre-Market | - | After-Market | 31.50 | ||
| - - | 0.15 0.48% |
| Target Price | - | Analyst Rating | — — 0.00 | |
| Potential % | - | Finscreener Ranking | — - | |
| Insiders Trans % 3/6/12 mo. | -/100/100 | Value Ranking | ★★★★★ 67.85 | |
| Insiders Value % 3/6/12 mo. | -/100/100 | Growth Ranking | — - | |
| Insiders Shares Cnt. % 3/6/12 mo. | -/100/100 | Income Ranking | ★★★★★ 72.31 | |
| Price Range Ratio 52W % | 22.51 | Earnings Rating | — | |
| Market Cap | 1.03B | Earnings Date | - | |
| Alpha | 0.00 | Standard Deviation | 0.07 | |
| Beta | 1.18 |
Today's Price Range 31.2131.70 | 52W Range 27.4544.78 |
Summary:
Sell
| Technical Indicators: | Neutral |
| Moving Averages: | Strong Sell |
| Performance | |||
|---|---|---|---|
| 1 Week | 0.42% | ||
| 1 Month | 0.45% | ||
| 3 Months | 8.37% | ||
| 6 Months | 3.57% | ||
| 1 Year | -28.05% | ||
| 3 Years | 8.07% | ||
| 5 Years | 5.63% | ||
| 10 Years | - |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | 17.77 | |||
ROE last 12 Months | 30.38 | |||
ROA (5Y Avg) | 11.57 | |||
ROA last 12 Months | 11.08 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | - | |||
Return on invested Capital Q | - | |||
Return on invested Capital Y | - | |||
Assets Turnover | -0.40 | |||
Receivables Turnover | - |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 29.50 | ||||
| 6.13 | ||||
| -1.75 | ||||
| 18.60 | ||||
| 83.00 | ||||
| -6.38 | ||||
| 0.88 | ||||
| 33.61 | ||||
| - | ||||
| Forward PE | - | |||
| PEG | - |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| 0.00 | ||||
| 0.00 | ||||
| - | ||||
| Leverage Ratio | 1.00 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| 102.60 | ||||
| 99.94 |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| -554 204 000.00 | ||||
| -17.27 | ||||
| 234.73 | ||||
| - |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 9.90 | ||||
| 3.00 | ||||
| 45.77 | ||||
| - | ||||
| Payout ratio | 9.00 |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| Next Report Date | - |
| Estimated EPS Next Report | - |
| Estimates Count | - |
| EPS Growth Next 5 Years % | - |
| Volume Overview | |
|---|---|
| Volume | 72.94K |
| Shares Outstanding | 33.00K |
| Shares Float | 32.08M |
| Trades Count | 1.26K |
| Dollar Volume | 2.29M |
| Avg. Volume | 107.20K |
| Avg. Weekly Volume | 72.70K |
| Avg. Monthly Volume | 107.83K |
| Avg. Quarterly Volume | 141.07K |
BlackRock Science and Technology Trust of Beneficial Interest (NYSE: BST) stock closed at 31.35 per share at the end of the most recent trading day (a -1.42% change compared to the prior day closing price) with a volume of 72.94K shares and market capitalization of 1.03B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Asset Management industry, Financial Services sector and employs 0 people. BlackRock Science and Technology Trust of Beneficial Interest CEO is John M. Perlowski.
The one-year performance of BlackRock Science and Technology Trust of Beneficial Interest stock is -28.05%, while year-to-date (YTD) performance is 10.5%. BST stock has a five-year performance of 5.63%. Its 52-week range is between 27.45 and 44.775, which gives BST stock a 52-week price range ratio of 22.51%
BlackRock Science and Technology Trust of Beneficial Interest currently has a PE ratio of 29.50, a price-to-book (PB) ratio of 6.13, a price-to-sale (PS) ratio of -1.75, a price to cashflow ratio of 18.60, a PEG ratio of 2.32, a ROA of 11.08%, a ROC of -% and a ROE of 30.38%. The company’s profit margin is 99.94%, its EBITDA margin is -%, and its revenue ttm is $-554 204 032.00 , which makes it $-17.27 revenue per share.
Of the last four earnings reports from BlackRock Science and Technology Trust of Beneficial Interest, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. BlackRock Science and Technology Trust of Beneficial Interest’s next earnings report date is -.
The consensus rating of Wall Street analysts for BlackRock Science and Technology Trust of Beneficial Interest is — (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for BlackRock Science and Technology Trust of Beneficial Interest stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
BlackRock Science and Technology Trust of Beneficial Interest has a dividend yield of 9.90% with a dividend per share of $3.00 and a payout ratio of 9.00%.
BlackRock Science and Technology Trust of Beneficial Interest has a Sell technical analysis rating based on Technical Indicators (ADX : 18.93, ATR14 : 0.62, CCI20 : -34.61, Chaikin Money Flow : 0.16, MACD : -0.14, Money Flow Index : 38.47, ROC : -2.34, RSI : 46.86, STOCH (14,3) : 48.39, STOCH RSI : 0.36, UO : 53.90, Williams %R : -51.61), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of BlackRock Science and Technology Trust of Beneficial Interest in the last 12-months were:
BlackRock Science and Technology Trust of Beneficial Interest
BlackRock Science and Technology Trust is a closed-end management investment company. Its investment objective is to provide income and total return through a combination of current income, current gains, and long-term capital appreciation. It focuses on investing, under a normal market condition in equity securities of science and technology companies.
CEO: John M. Perlowski
Telephone: +1 800 882-0052
Address: 100 Bellevue Parkway, Wilmington 19809, DE, US
Number of employees: 0
